Characterization of retroviruses from patients with multiple sclerosis

Acta Neurologica Scandinavica, Supplement

Volumn 95, Issue 169, 1997, Pages 49-58

  Christensen, T ^a   Jensen, A W ^a   Munch, M ^a   Haahr, S ^a   Dissing Sorensen P ^a   Riemann, H ^a   Hansen, H J ^a   Moller Larsen, A ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

multiple sclerosis; myelopathy; retrovirus

Indexed keywords

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MOLECULAR CLONING; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD DISEASE; ARTICLE; B LYMPHOCYTE; CELL LINE; ELECTRON MICROSCOPY; ENVELOPE GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; STRUCTURAL GENE; VIROLOGY; VIRUS INCLUSION;

AUTOANTIGEN; VIRUS DNA; VIRUS PROTEIN;

AUTOANTIGENS; B-LYMPHOCYTES; CELL LINE; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, VIRAL; GENES, ENV; GENES, GAG; GENES, POL; HERPESVIRUS 4, HUMAN; HUMANS; INCLUSION BODIES, VIRAL; MICROSCOPY, ELECTRON; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; RETROVIRIDAE PROTEINS;

EID: 0030631058     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. UTZ U, BlDDISON WE, McFARLAND HF, MCFARLIN DE, FLERLAGE M, MARTIN R. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 1993: 364: 243-247.
2. KOPROWSKI K, DEFREITAS EC, HARPER ME et al. Multiple sclerosis and the human T-cell lymphotropic retroviruses. Nature 1985: 318: 154-160.
3. REDDY EP, SANDBERG-WOLHEIM M, METTUS RV, RAY PE, DEFREITAS E, KOPROWSKI H. Amplification and molecular cloning of HTLV-1 sequences from DNA of multiple sclerosis patients. Science 1989: 243: 529-533.
4. PERRON H, GENY C, LAURENT A et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989: 140: 551-561.
5. PERRON H, LALANDE B, GRATACAP B et al. Isolation of retrovirus from patients with multiple sclerosis. Lancet 1991: 337: 862-863.
6. HAAHR S, SOMMERLUND M, MOLLER-LARSEN A, NIELSEN R, HANSEN HJ. Just another dubious virus in cells from a patient with multiple sclerosis? Lancet 1991: 337: 863-864.
7. SOMMERLUND M, PALLESEN G, MOLLER-LARSEN A, HANSEN HJ, HAAHR S. Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand 1993: 87: 71-76.
8. MUNCH M, MOLLER-LARSEN A, CHRISTENSEN T, MORLING N, HANSEN HJ, HAAHR S. B-LYMPHOBLASTOID CELL LINES FROM MULTIPLE SCLEROSIS PATIENTS AND A HEALTHY CONTROL PRODUCING A PUTATIVE NEW HUMAN RETROVIRUS AND EPSTEIN-BARR VIRUS. MULTIPLE SCLEROSIS 1995: 1: 78-81.
9. PALLESEN G, HAMILTON-UUTOIT SJ, ROWE L, YOUNG LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991: 337: 320322.
10. SILVER J, MAUDRU T, FUJITA K AND REPASKE R. An RTPCR assay for the enzyme activity of RT capable of detecting single virions. Nucleic Acids Res 1993: 21: 35933594.
11. PYRA H, BONI J AND SCHüPBACH J. Ultrasensitive retrovirus detection by a RT assay based on product enhancement. Proc Natl Acad Sei U S A 1994: 91:1544-1548.
12. PLOUG M, RöNNE E, BEHRENDT N, JENSEN AL, BLASI F, DANO K. Cellular receptor for urokinase plasminogen activator: carboxy-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 1990: 266: 1926-1933.
13. SEIKI M, HATTORI S, YOSHIDA M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sei USA 1983: 80: 3618-3622.
14. WOOD HC AND WREGHITT TG. TECHNIQUES. In: WREGHITT TG, MORGAN-CHAPNER P, ed. ELISA in the clinical microbiology laboratory. London: Public Health Laboratory Service, 1990: 6-22.
15. MIYAUCHI M, MARUYAMA K. Morphological and antigenic variations of human T cell leukaemia virus type 1 particles in human lymphocytes. J Electron Microsc 1990: 39: 145154.
16. DOBROTA M, HINTON R. Conditions for density gradient separations. In: RICKWOOD D, ed. Preparative centrifugation. A practical approach. New York: IRL Press at Oxford University Press, 1992.
17. VARMUS H, BROWN P. Retroviruses. In: BERG DE, HOWE MM, ed. Mobile DNA. Washington, DC: American Society for Microbiology, 1989: 53-108.
18. FRITSCH EF, TEMIN HM. Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J Virol 1977: 24: 461-469.
19. STEVENSON M, STANWICK TL, DEMPSEY MP, LAMONICA ÇA. HIV-1 replication is controlled at the level of T-cell activation and proviral integration. EMBO J 1990: 9: 1551-1560.
20. GESSAIN A, BARIN F, VERNANT JC et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985 ii: 407-409.
21. PALKER, TJ. Mapping of epitopes on human T-cell leukemia virus type 1 envelope protein. In: BLATTNER WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990: 435-445.
22. MONTAGNIER L, GRUEST J, CHAMARET S et al. Adaptation of lymphâdenopathy associated virus (LAV) to replicate in EBV-transformed B lymphoblastoid cell lines. Science 1984: 225: 63-66.
23. SALAHUDDIN SZ, ABLASHI DV, HUNTER EA et al. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens. Int J Cancer 1987: 39: 198202.
24. ISRAEL S, MENDELOVITZ M, HONIGMAN A. Transactivation of human T-cell leukemia virus type 1 by herpes simplex virus type 1. Virus Genes 1995: 9: 269-276.
25. FENG CP, KULKA M, AURELIAN L. The GGTCA palindrome and coanate cellular factors in trans-regulation of human immunodeficiency virus long terminal repeat by herpes simplex virus. J Gen Virol 1993: 74: 715-723.
26. PAYA CV, VIRELIZIER JL, MICHELSON S. Modulation of Tcell activation through protein kinase C- or A-dependent signalling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate-early proteins. J Virol 1991: 65: 5477-5484.
27. KURAYA M, SATO T, FUJITA T. C3d and Epstein-Barr virus (CR2/CD21 ligands) stimulate cells of an HTLV-1 line, MT-2. Microbiol Immunol 1995: 39: 145-151.
28. LIN JC. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5′ long terminal repeat. Biochem Biophys Res Commun 1993: 195: 242-249.
29. SCALA G, QUINTO I, Ruocco MR et al. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J Virol 1993: 67: 2853-2861.
30. ASTRIN SM, LAURENCE J. Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes. Ann N Y Acad Sei 1992: 651: 422-432.
31. LARDELLI P, MANZANO D, STEINBERG SM et al. Correlative detection of human immunodeficiency virus (HIV) antigen p24 and Epstein-Barr virus DNA in vitro: clinical influence on HIV infection. Microbiol Immunol 1992: 36: 905-909.
32. KASHANCHI F, THOMPSON J, SADAIE MR. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the Sall-L fragment of human herpesvirus 6. Virology 1994: 201: 95-106.
33. SIECZKOWSKI L, CHANDRAN B, WOOD C. The human immunodeficiency virus tat genes enhances replication of human herpesvirus-6. Virology 1995: 211: 544-553.
34. Lusso P, GALLO RC. Human herpesvirus 6 in AIDS. Immunol Today 1995: 16:67-71.
35. BIGONI B, DOLCETTI R, DE-LELLIS L et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996: 173: 542-549.
36. URNOVITZ HB, MURPHY WH. Human endogenous retroviruses: nature, occurrence and clinical implications in human disease. Clin Microbiol Rev 1996: 9: 72-99.